David Pan watches the Vaccine, Immunity, and Cancer Program’s robot that performs automated testing for anti-HPV antibodies.

FREDERICK, Md. -- Ligia Pinto, Ph.D., sees science as a way to change lives and help people in need—and that is precisely what a study recently co-authored by her team at the Frederick National Laboratory for Cancer Research and collaborators at the H. Lee Moffitt Cancer Center and Research Institute and Weill Cornell Medicine holds promise to do.

HIV image. Photo courtesy National Institute of Allergy and Infectious Diseases.

FREDERICK, Md. -- Recent scientific papers co-authored by researchers at the Frederick National Laboratory for Cancer Research present novel discoveries about HIV and one similar infection from three fields of inquiry about the virus, all with the potential to further discoveries leading to prevention or treatment of HIV infection.

NHP Models- Medicine, Simian Immunodeficiency Virus (SIV), Simian/Human Immunodeficiency Virus (SHIV), FNL SHIVs, FNL Barcoded SIV, Analysis, Study Design

FREDERICK, Md. -- Scientists at the Frederick National Laboratory for Cancer Research, the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center, and a team of collaborators have filled a gap in HIV research by developing 38 new simian/human immunodeficiency viruses (SHIVs) for prevention and treatment studies. The viruses are available to the scientific community through the national laboratory’s AIDS and Cancer Virus Program (ACVP).

Pages